AzTrials
AzTrials

Body Dysmorphic DisorderNCT06896435

Smart-Phone Safety Behavior Fading Intervention for Appearance Concerns (Open ARSB Study)

A study testing Safety Behavior Fading for Appearance Concerns and Relaxing Video in people with Body Dysmorphic Disorder and Social Anxiety Disorder, run by Florida State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a relaxing video intervention for appearance concerns. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
Safety Behavior Fading for Appearance Concerns and Relaxing Video
Could I receive a placebo?
No, everyone receives an active treatment
How many people
401 participants
Where
1 siteUnited States
Study dates
15 Apr 2025to 8 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Seeking treatment for appearance concerns

Who cannot join

  • Currently receiving treatment (therapy, counseling, etc.) for anxiety, depression, eating disorder, or body image/appearance concerns
  • If applicable, unstable psychiatric medication usage any time over the past 4 weeks

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Florida State University

    Tallahassee, Florida, 32304

Other trials in United States

About this study

Official title: Smart-Phone Safety Behavior Fading Intervention for Appearance Concerns

The current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a relaxing video intervention for appearance concerns.

Read the detailed description

Description: Appearance-related safety behavior fading intervention procedures will follow methodology previously used in the Cougle Lab. The safety behavior fading intervention is designed to target a decrease or elimination of appearance-related safety behaviors. Individuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their endorsed appearance-related safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day. The daily reminder will include the following language: "Hi! This is a friendly reminder to avoid using your checklist behaviors. Please tap the link below to access today's checklist: [link to checklist]." Text messages will be delivered using EZtexting a text messaging platform used for research and marketing. Note that no identifying information will be included in this platform. Each participants phone number will be accompanied with a anonymized ID code. Individuals randomly assigned to the relaxing video condition will receive a total of 4 videos over the course of a month (1 video per week, 15 minutes each) wherein participants will be invited to close their eyes and focus their attention on the present moment while listening to relaxing piano music and songbirds.

Being tested
Safety Behavior Fading for Appearance Concerns, Relaxing Video
Keywords
appearance concerns, safety behavior
Medical subject headings
Body Dysmorphic Disorders, Phobia, Social, Feeding and Eating Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Safety Behavior Fading for Appearance ConcernsBehavioural

    Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.

  • Relaxing VideoBehavioural

    Participants are asked to view weekly videos lasting 15 minutes each to engage in relaxation exercises.

Study groups in NCT06896435
Study groupRoleWhat they receive
Safety Behavior FadingExperimentalIndividuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their endorsed appearance-related safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they engaged in each safety behavior over the previous day.
Receives: Behavioral: Safety Behavior Fading for Appearance Concerns
Relaxing VideoActive comparatorIndividuals randomly assigned to the relaxing video condition will receive a total of 4 videos over the course of a month (1 video per week, 15 minutes each) wherein participants will be invited to close their eyes and focus their attention on the present moment while listening to relaxing piano music and songbirds.
Receives: Behavioral: Relaxing Video

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Social Appearance Anxiety Scale (SAAS; Hart et al., 2008)

    Self-report scale that measures appearance anxiety symptoms. Scores range from 16 to 80 with higher scores indicating higher levels of appearance concerns.

    Measured: Day 0, Day 28, Day 56

  2. Social Phobia Inventory (SPIN; Connor et al., 2000)

    Self-report scale that measures social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety.

    Measured: Day 0, Day 28, Day 56

  3. Credibility and Expectancy Questionnaire (Devilly & Borkovec, 2000).

    Self-report scale for measuring treatment expectancy and rationale credibility for use in clinical outcome studies. Three items are rated on a 0-10 scale and one item is rated on a 0-100 scale with higher scores meaning greater expectancy and credibility.

    Measured: Day 0

  4. Eating Disorder Inventory (EDI; Garner et al., 1983).

    Self-report scale for measuring drive for thinness, bulimia, and body dissatisfaction for use in clinical outcome studies. Each item is rated on a 0-5 scale with a total score range of 0-125 with higher scores indicating greater drive for thinness, bulimia, and body dissatisfaction.

    Measured: Day 0, Day 28, Day 56

  5. Appearance Behaviors Checklist past-week version (author constructed)

    Self-report scale used to measure frequency of engaging in appearance-related safety behaviors. This scale will be used as a manipulation check. Each item is rated on a 0 to 10 scale. Total scores range from 0 to 130 with higher scores indicating greater engagement in appearance-related safety behaviors

    Measured: Day 0, Day 28, Day 56

Secondary outcomes (3)
  1. Distress Intolerance Index (McHugh & Otto, 2012)

    Self-report scale for measuring tolerance to distress for use in clinical outcome studies. Each item is rated on a 0-4 scale with a total score range of 0-40 with higher scores indicating greater intolerance of distress.

    Measured: Day 0, Day 28, Day 56

  2. Frost Multidimensional Perfectionism Scale-Concerns over mistakes subscale (Frost et al., 1990)

    Self-report scale for measuring concerns for making mistakes for use in clinical outcome studies. Each item is rated on a 0-4 scale with a total score range of 0-36 with higher scores indicating greater concerns for making mistakes.

    Measured: Day 0, Day 28, Day 56

  3. Center for Epidemiologic Studies Depression Scale-10 (CESD; Andreson, 1994)

    Self-report measure of depression symptom severity. Each item is rated on a 0 to 3 scale. Total scores range from 0 to 30 with higher scores indicating greater depression severity.

    Measured: Day 0, Day 28, Day 56

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2025
  2. Study start15 Apr 2025
  3. Primary completion8 Sep 2025
  4. Study completion8 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomized to one of two conditions
Masking
None (open label)
Enrolment
401 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06896435
Sponsor's protocol ID
STUDY00005977
Status last verified
Sep 2025
First submitted
20 Mar 2025
Last updated
15 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Patel TA, Cougle JR. Who benefits from a digital intervention for appearance concerns? A randomized controlled trial of a large mixed-gender sample. J Consult Clin Psychol. 2026 Apr;94(4):216-227. doi: 10.1037/ccp0001007.

    PubMed 42080861

Questions about this trial

What is this clinical trial studying?

A study testing Safety Behavior Fading for Appearance Concerns and Relaxing Video in people with Body Dysmorphic Disorder and Social Anxiety Disorder, run by Florida State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Social Appearance Anxiety Scale (SAAS; Hart et al., 2008) (time frame: Day 0, Day 28, Day 56). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06896435, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in